Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep 1:112:97-104.
doi: 10.1016/j.placenta.2021.07.288. Epub 2021 Jul 15.

Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome

Affiliations
Case Reports

Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome

Amine Bouachba et al. Placenta. .

Abstract

Introduction: Pregnant women with covid-19 are more likely to experience preterm birth. The virus seems to be associated with a wide range of placental lesions, none of them specific.

Method: We collected cases of Covid-19 maternal infection during pregnancy associated with poor pregnancy outcomes, for which we received the placenta. We studied clinical data and described pathological findings of placenta and post-mortem examination of fetuses. We performed an immunohistochemical study and RT-PCR of SARS-Cov-2 on placenta samples.

Results: We report 5 cases of poor fetal outcome, 3 fetal deaths and 2 extreme premature neonates, one with growth restriction, without clinical and biological sign of SARS-Cov-2 infection. All placenta presented massive perivillous fibrin deposition and large intervillous thrombi associated with strong SARS-Cov-2 expression in trophoblast and SARS-CoV-2 PCR positivity in amniotic fluid or on placenta samples. Chronic histiocytic intervillositis was present in 4/5 cases. Placental ultrasound was abnormal and the sFLT1-PIGF ratio was increased in one case. Timing between mothers' infection and the poor fetal outcome was ≤10 days in 4 cases. The massive placental damage are directly induced by the virus whose receptors are expressed on trophoblast, leading to trophoblast necrosis and massive inflammation in villous chamber, in a similar way it occurs in diffuse alveolar damage in adults infected by SARS-Cov-2.

Discussion: SARS-Cov-2 can be associated to a rare set of placental lesions which can lead to fetal demise, preterm birth, or growth restriction. Stronger surveillance of mothers infected by SARS-Cov-2 is required.

Keywords: COVID-19; Fetal demise; Histopathology; Placenta; Prenatal ultrasounds; SARS-Cov-2; sFLT1/PIGF.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1
Fig. 1
Prenatal ultrasounds and gross features of placenta (case 5): A: prenatal ultrasounds at 26 GW: hypoechoic lacunae (red arrows) B: prenatal ultrasounds at 26 GW: coexistence of hyperechoic lesion (green arrows) and hypoechoic lesion (red arrows) suggestive of calcification and infarction respectively. Blue circle: Fetus C: gross features on cut sections after formalin fixation: whitish mottled net-like appearance involving at least 80% of parenchyma suggestive of massive fibrin deposition D: gross features on cut sections after formalin fixation: same anomalies on higher magnification.
Fig. 2
Fig. 2
Microscopic features of the placenta on HES (Hematoxylin Eosin Saffron) A & B: x 5: 2 different cut sections showing large intervillous thrombi (black arrows) C: x 200: MPFD with trophoblast necrosis (black arrow), fibrin deposits (green arrow) along with CHI (blue arrow).
Fig. 3
Fig. 3
Immunohistochemical study A: CD68 antibody x 80: numerous histiocytes in the intervillous chamber B: CD3 antibody x 80: numerous lymphocytes inside or adjacent to the trophoblast.
Fig. 4
Fig. 4
Immunohistochemical study of Sars-Cov2 on placenta A: case 2 (34+5 GW) x 25: diffuse and strong expression on trophoblast B: negative control x 25: placenta from annon-infected mother at 34 GW: no expression on trophoblast C: case 4 × 200 (22 +4 GW): diffuse and strong expression on trophoblast D: negative control x 200: placenta from a non-infected mother at 22 GW: no expression on trophoblast.

References

    1. Inst. Pasteur.; 2020. Maladie Covid-19 (nouveau coronavirus)https://www.pasteur.fr/fr/centre-medical/fiches-maladies/maladie-covid-1...
    1. Schwartz D.A. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch. Pathol. Lab Med. 2020 doi: 10.5858/arpa.2020-0901-SA. - DOI - PubMed
    1. Transplacental transmission of SARS-CoV-2 infection | Nat. Commun., (n.d.). https://www.nature.com/articles/s41467-020-17436-6 (accessed February 3, 2021). - PMC - PubMed
    1. Lü M., Qiu L., Jia G., Guo R., Leng Q. Single-cell expression profiles of ACE2 and TMPRSS2 reveals potential vertical transmission and fetus infection of SARS-CoV-2. Aging. 2020;12:19880–19897. doi: 10.18632/aging.104015. - DOI - PMC - PubMed
    1. Allotey J., Stallings E., Bonet M., Yap M., Chatterjee S., Kew T., Debenham L., Llavall A.C., Dixit A., Zhou D., Balaji R., Lee S.I., Qiu X., Yuan M., Coomar D., Sheikh J., Lawson H., Ansari K., van Wely M., van Leeuwen E., Kostova E., Kunst H., Khalil A., Tiberi S., Brizuela V., Broutet N., Kara E., Kim C.R., Thorson A., Escuriet R., Oladapo O.T., Mofenson L., Zamora J., Thangaratinam S. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320. - DOI - PMC - PubMed

Publication types

MeSH terms